search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
21


at 10,000Da. The remaining glycans were then converted to free reducing end glycans by dilution of the sample with 1% FA to obtain an antibody concentration of 0.1mg/ml; incubation for 2h at 37ºC.


Conclusion: This article provides a technical description of the mAb-Glyco Chip Kit that was designed for fast and automated characterisation of N- glycans from monoclonal antibodies (mAb). It was demonstrated that the complete workflow including on-chip deglycosylation of the mAb as well as chromatographic separation, and Q-TOF detection of the


cleaved glycans, and data processing can be completed within a 20 min time period.


Data have verified chip stability, reproducibility and lifetime as well as excellent comparability of results obtained from chip analysis to those obtained from a typical standard workflow (that in this case took 5-6 hours to complete). It can be concluded that the mAb-Glyco Chip Kit provides a robust workflow solution that helps to remove a major bottleneck during the development phase of mAb-based biological drugs allowing the analyst to quickly provide answers.


References [1] R. Jefferis, Nature Reviews Drug Discovery 8 (2009) 226.


[2] C. Huhn, M. Selman, L. Ruhaak, A. Deelder, Wuhrer, Proteomics, 9 (2009) 882.


[3] mAb-Glyco Chip User’s Guide; 2010; G4240-90020 (or 2011; G4240-90022).


[4] Technical Note, (2005) Publication Number 5989-3627EN.


[5] H. Yin, K. Killeen, R. Brennen, D. Sobek, M. Werlich, T. van de Goor, Anal. Chem., 77 (2005) 527.


[6] H. Yin, K. Killeen, J. Sep. Sci., 30 (2007) 1427. [7] M. Bynum, H. Yin, K. Felts, Y. Lee, C. Monell, K. Killeen, Anal. Chem., 81 (2009) 8818.


[8] J.R.Rasmussen, J. Davis, J. Risley, R. Van Etten, J. Am. Chem. Soc., 114 (1992) 1124.


The Nexera MP UHPLC Front End System for LC/MS Perfect for LC/MS Analysis in Drug Detection Processes


Shimadzu, has introduced the Nexera MP UHPLC as a Front End system for LC/MS. The system premiered this summer in Europe at the HPLC 2011 show in Budapest, Hungary. The Nexera MP is perfect for LC/MS analysis conducted in


pharmacokinetics and synthesis stages in drug detection processes. The new SIL-30ACMP Multiplate Autosampler used in the Nexera MP is best suited for LC/MS analysis and has the industry-best micro-volume injection repeatability, the world’s highest injection speed and the lowest carryover. Combining the Nexera MP with Shimadzu’s LCMS-8030 Triple Quadrupole Mass Spectrometer or the LCMS-2020 Single Quadrupole Mass Spectrometer creates a system for quick analysis of multiple samples with high accuracy. For more Information visit: www.shimadzu.co.uk


ECD Services - are your ECD’s legal ? Wipe Testing


ECD’s are required by law to be tested once per year to check for radioactive leaking


ECD Refurbishment


Detectors can be cleaned & refurbished to return stability lost by contamination


Removal of unwanted ECD’s If a detector is no longer required, Ellutia can take ownership of the detector where it will be assesed for re-use or disposal


www.ellutia.com/ECD.html Chromatography Solutions


Tel: +44(0)1353 669916 Fax: +44 (0)1353 669917 Web: www.ellutia.com Email: info@ellutia.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52